Alex Gorsky, J&J CEO (Evan Vucci/AP Images)
Covid-19 roundup: J&J enters PhIII with a two-dose regimen to play safe; AstraZeneca, Oxford tout promising data in elderly
Johnson & Johnson had the first single-dose Covid-19 vaccine to enter Phase III trials — but to be cautious, the pharma is launching a second Phase …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
